{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:59:48Z","timestamp":1785373188579,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-03864-5","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T08:32:33Z","timestamp":1748507553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["TFE3-rearranged PEComa-like neoplasm of the kidney with carcinoma-like morphology and rapid progression: a case report"],"prefix":"10.1186","volume":"23","author":[{"given":"Zhao-Jing","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Chu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Wu","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mian-Fu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Jie","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"issue":"4","key":"3864_CR1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/path.5470","volume":"251","author":"XT Wang","year":"2020","unstructured":"Wang XT, Fang R, Zhang RS, et al. Malignant melanotic Xp11 neoplasms exhibit a clinicopathologic spectrum and gene expression profiling akin to alveolar soft part sarcoma: a proposal for reclassification. J Pathol. 2020;251(4):365\u201377.","journal-title":"J Pathol"},{"issue":"7","key":"3864_CR2","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1097\/PAS.0000000000002218","volume":"48","author":"P Argani","year":"2024","unstructured":"Argani P, Gross JM, Baraban E, et al. TFE3-rearranged PEComa\/PEComa-like neoplasms: report of 25 new cases expanding the clinicopathologic spectrum and highlighting its association with prior exposure to chemotherapy. Am J Surg Pathol. 2024;48(7):777\u201389.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"3864_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.pathol.2020.08.008","volume":"53","author":"A Cali\u00f2","year":"2021","unstructured":"Cali\u00f2 A, Brunelli M, Segala D, et al. Angiomyolipoma of the kidney: from simple hamartoma to complex tumour. Pathology. 2021;53(1):129\u201340.","journal-title":"Pathology"},{"issue":"5","key":"3864_CR4","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00428-014-1655-x","volume":"465","author":"Q Shen","year":"2014","unstructured":"Shen Q, Rao Q, Xia Q, et al. Perivascular epithelioid cell tumor (PEComa) with TFE3 gene rearrangement: clinicopathological, immunohistochemical, and molecular features. Virchows Arch. 2014;465(5):607\u201313.","journal-title":"Virchows Arch"},{"issue":"6","key":"3864_CR5","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1097\/PAS.0000000000000631","volume":"40","author":"P Argani","year":"2016","unstructured":"Argani P, Zhong M, Reuter VE, et al. TFE3-fusion variant analysis defines specific clinicopathologic associations among Xp11 translocation cancers. Am J Surg Pathol. 2016;40(6):723\u201337.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"3864_CR6","doi-asserted-by":"publisher","first-page":"e692","DOI":"10.1016\/j.clgc.2020.04.004","volume":"18","author":"M Vannucchi","year":"2020","unstructured":"Vannucchi M, Minervini A, Salvi M, et al. TFE3 gene rearrangement in perivascular epithelioid cell neoplasm (PEComa) of the genitourinary tract. Clin Genitourin Canc. 2020;18(6):e692\u201397.","journal-title":"Clin Genitourin Canc"},{"issue":"1","key":"3864_CR7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/PAS.0000000000002317","volume":"49","author":"O Abbas","year":"2025","unstructured":"Abbas O, Al-Obaidy KI. TFE3 -rearranged PEComa-like neoplasm of the kidney: a case report and letter to the editor. Am J Surg Pathol. 2025;49(1):94\u20135.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"3864_CR8","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/his.15304","volume":"85","author":"A Agaimy","year":"2024","unstructured":"Agaimy A, Acosta AM, Cheng L, et al. TFE3-rearranged nonmelanotic renal pecoma: a case series expanding their phenotypic and fusion landscape. Histopathology. 2024;85(5):783\u201393.","journal-title":"Histopathology"},{"issue":"3","key":"3864_CR9","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/his.15087","volume":"84","author":"M Zhao","year":"2024","unstructured":"Zhao M, Huang Y, Yin X, et al. PEComa with ASPSCR1::TFE3 fusion: expanding the molecular genetic spectrum of TFE3-rearranged pecoma with an emphasis on overlap with alveolar soft part sarcoma. Histopathology. 2024;84(3):482\u201391.","journal-title":"Histopathology"},{"issue":"10","key":"3864_CR10","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1016\/j.asjsur.2023.05.011","volume":"46","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Shi H, Zhang J. Malignant pecoma located in ureter with a positive TFE3 immunohistochemical staining: a case report. Asian J Surg. 2023;46(10):4560\u201362.","journal-title":"Asian J Surg"},{"issue":"4","key":"3864_CR11","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/PAS.0b013e31818fbdff","volume":"33","author":"P Argani","year":"2009","unstructured":"Argani P, Aulmann S, Karanjawala Z, et al. Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma. Am J Surg Pathol. 2009;33(4):609\u201319.","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"3864_CR12","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1097\/PAS.0b013e3181ba7a5f","volume":"33","author":"IW Chang","year":"2009","unstructured":"Chang IW, Huang HY, Sung MT. Melanotic Xp11 translocation renal cancer: a case with PSF-TFE3 gene fusion and up-regulation of melanogenetic transcripts. Am J Surg Pathol. 2009;33(12):1894\u2013901.","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"3864_CR13","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1097\/PAS.0b013e31826277a9","volume":"36","author":"RD LeGallo","year":"2012","unstructured":"LeGallo RD, Stelow EB, Sukov WR, et al. Melanotic Xp11.2 neoplasm of the ovary: report of a unique case. Am J Surg Pathol. 2012;36(9):1410\u201314.","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"3864_CR14","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1097\/PAS.0000000000000502","volume":"39","author":"Q Rao","year":"2015","unstructured":"Rao Q, Shen Q, Xia QY, et al. PSF\/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity. Am J Surg Pathol. 2015;39(9):1181\u201396.","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"3864_CR15","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1097\/PAS.0000000000001894","volume":"46","author":"P Argani","year":"2022","unstructured":"Argani P, Wobker SE, Gross JM, et al. PEComa-like neoplasms characterized by ASPSCR1-TFE3 fusion: another face of TFE3-related mesenchymal neoplasia. Am J Surg Pathol. 2022;46(8):1153\u201359.","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"3864_CR16","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1097\/PAS.0b013e3181f17ac0","volume":"34","author":"P Argani","year":"2010","unstructured":"Argani P, Aulmann S, Illei PB, et al. A distinctive subset of PEComas harbors TFE3 gene fusions. Am J Surg Pathol. 2010;34(10):1395\u2013406.","journal-title":"Am J Surg Pathol"},{"issue":"5\u20136","key":"3864_CR17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1615\/CritRevOncog.2017020558","volume":"22","author":"XT Wang","year":"2017","unstructured":"Wang XT, Xia QY, Zhou XJ, et al. Xp11 translocation renal cell carcinoma and the mesenchymal counterparts: an evolving concept with novel insights on clinicopathologic features, prognosis, treatment, and classification. Crit Rev Oncog. 2017;22(5\u20136):481\u201397.","journal-title":"Crit Rev Oncog"},{"issue":"6343","key":"3864_CR18","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1126\/science.aag2553","volume":"356","author":"C Di Malta","year":"2017","unstructured":"Di Malta C, Siciliano D, Calcagni A, et al. Transcriptional activation of RagD GTPase controls mTORC1 and promotes cancer growth. Science. 2017;356(6343):1188\u201392.","journal-title":"Science"},{"issue":"1","key":"3864_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12957-021-02462-5","volume":"20","author":"R Purwar","year":"2022","unstructured":"Purwar R, Soni K, Shukla M, et al. TFE3-associated perivascular epithelioid cell tumor with complete response to mTOR inhibitor therapy: report of first case and literature review. World J Surg Oncol. 2022;20(1):62.","journal-title":"World J Surg Oncol"},{"key":"3864_CR20","doi-asserted-by":"publisher","first-page":"966818","DOI":"10.3389\/fonc.2022.966818","volume":"12","author":"N Zhang","year":"2022","unstructured":"Zhang N, Ren Y, Zan L, et al. Case report: kidney perivascular epithelioid cell tumor treated with anti-VEGFR tyrosine kinase inhibitor and MTOR inhibitor. Front Oncol. 2022;12:966818.","journal-title":"Front Oncol"},{"key":"3864_CR21","doi-asserted-by":"publisher","first-page":"582087","DOI":"10.3389\/fonc.2020.582087","volume":"10","author":"J Xu","year":"2020","unstructured":"Xu J, Gong X, Wu H, et al. Case report: Gastrointestinal pecoma with TFE3 rearrangement treated with anti-VEGFR TKI apatinib. Front Oncol. 2020;10:582087.","journal-title":"Front Oncol"},{"issue":"2","key":"3864_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1159\/000477434","volume":"10","author":"RJ Lin","year":"2017","unstructured":"Lin RJ, Melamed J, Wu J. PEComa with transcription factor E3 overexpression: a diagnostic and therapeutic challenge. Case Rep Oncol. 2017;10(2):531\u201333.","journal-title":"Case Rep Oncol"},{"key":"3864_CR23","doi-asserted-by":"crossref","unstructured":"Lee W, HaDuong J, Sassoon A et al. A liver transplant for local control in a pediatric patient with metastatic TFE3-associated perivascular epithelioid cell tumor (PEComa) to the liver. Case Rep Pathol. 2021; 2021:1\u201305.","DOI":"10.1155\/2021\/3924565"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03864-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03864-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03864-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T08:32:35Z","timestamp":1748507555000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03864-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3864"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03864-5","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"13 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the Southwest Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"206"}}